Impact Genomics, Inc. — Form D/A
Impact Genomics, Inc. of LA JOLLA, CA, a company, filed a Form D amendment with the SEC on 2017-01-30. The offering totals $10.2M, of which $10.2M was reported sold. Industry: Other.
Offering
- Filed: 2017-01-30
- Form: D/A
- Accession: 0001690870-17-000001
- Industry: Other
- Exemptions: 06b
- Total offering: $10.2M
- Amount sold: $10.2M
- Remaining: $9K
- Investors: 32
- Date of first sale: 2016-11-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-275823
Issuer
- Name: Impact Genomics, Inc.
- CIK: 0001690870
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 2645 RIDGEGATE ROAD, LA JOLLA, CA, 92037
- Phone: 215-519-6638
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Samuel Levy | Director | San Diego, CA |
| Kenneth Nesmith | Director | La Jolla, CA |
| John Spinosa | Director | La Jolla, CA |
| Samuel Levy | Executive Officer | San Diego, CA |
| Kenneth Nesmith | Executive Officer | La Jolla, CA |
| John Spinosa | Executive Officer | La Jolla, CA |
Other filings by this issuer (2)
More